Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × camrelizumab × Clear all

NCT04353479 2020-04-20

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute